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Fig. 1. One-way, valved, atrial septal patch. (From Luluaga IT, Yosifides de Luluagi I. Cierre gradual de 
las communicaciones interauriculares con severa hypertensión pulmonar: presentación de dos casos operados. 
Arch Fund Roux-Ocefa 1969;3:101-4; published with the permission of Roux-Ocefa Foundation.) 
5. Williams rJV, Salamonsen RF, Snell G, et al. Preliminary 
experience udth inhaled nitric oxide for acute pulmonary 
hypertension after heart transplantation. J Heart Lung 
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Reply to the Editor: 
The observations described by George, Black, and Boscoe 
are interesting. They appear to corroborate the beneficial 
effects of nitric oxide that my colleagues and I described-- 
reduction of acutely increased pulmonary vascular resistance 
after cardiopulmonary b pass (CPB) during implantation of 
a left ventricular assist system (LVAS). 
We would like to comment specifically on their question 
about the 30-minute delay that we observed before the 
beneficial effect of nitric oxide administration became 
apparent. 
We agree that nitric oxide administration is followed by 
a rapid (i.e., <5 minutes) decrease in pulmonary vascular 
resistance. In fact, we observed a rapid decrease in 
pulmonary artery pressure. However, inasmuch as our 
patient was supported by CPB, right ventricular preload 
was reduced, so that the LVAS could not fill completely 
and LVAS output was thus unable to increase signifi- 
cantly. However, peak LVAS filling volume rapidly in- 
creased, which onfirmed that the patient's hemodynamic 
status had improved. After almost 30 minutes the situa- 
tion appeared to be stable, with no further decrease in 
pulmonary vascular esistance or increase in pump filling 
rate. We completely agree that this beneficial effect was a 
combination of nitric oxide administration, which reduces 
right ventricular afterload, and possible recovery of right 
ventricular ~unction as a result of prolonged CPB. This 
was precisely what we hoped to achieve by waiting 30 
minutes with the patient supported by complete CPB. 
Nevertheless, when CPB support was progressively re- 
duced, so that right ventricular preload increased, the 
beneficial effects of a reduced right ventricular afterload 
became vident, as indicated by satisfactory LVAS output. 
Regarding the problem of demonstrating the beneficial 
effects of nitric oxide administration, we took great care to 
maintain an appropriate nitric oxide concentration when 
the patient was transported to the intensive care unit or 
when the cylinder was changed. 
Finally, George, Black, and Boscoe expressed concern 
regarding the poor prognosis of bridge to transplantation 
with an implantable LVAS alone in patients requiring 
nitric oxide administration. We still believe that this 
therapeutic approach allowed us to reduce the increase in 
pulmonary vascular esistance resulting from CPB, thus 
affording the possibility for progressive right ventricular 
recovery. This apparently was the case with our patient, 
who undelwent successful transplantation 3 months after 
LVAS implantation. 
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Valved atrial septal patch 
To the Editor: 
I read with interest he article of Ad and associates 1 
from the Beilinson and Tel-Aviv Medieal Centers on their 
experimental results achieved with a one-way, valved, 
atrial septal patch. The pateh was to be used in the 
management of postoperative right heart failure in pa- 
tients with congenital heart defects characterized by 
hypoplastic right ventricle or pulmonary hypertension. At 
the end of the article they suggested that a prospective 
clinical trial should be done. 
In 1967, Luluaga and Yosifides de Luluaga performed 
a similar operation to treat atrial septal defect with severe 
pulmonary hypertension i two patients, with uneventful 
recovery. The photograph of the patch (Fig. 1) is similar to 
that used in dogs by Ad and assoeiates. 
